Adamas Pharma (ADMS) Misses Q3 EPS by 6c
Get Alerts ADMS Hot Sheet
Join SI Premium – FREE
Adamas Pharma (NASDAQ: ADMS) reported Q3 EPS of ($1.04), $0.06 worse than the analyst estimate of ($0.98).
For earnings history and earnings-related data on Adamas Pharma (ADMS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share